AIH:NSD-Aesthetic Medical Intl Holding Ltd (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 1.22

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

312.00

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


AIH Stock Forecast & Price:
Based on the Aesthetic Medical Intl Holding Ltd stock forecasts from 0 analysts, the average analyst target price for Aesthetic Medical Intl Holding Ltd is not available over the next 12 months. Aesthetic Medical Intl Holding Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aesthetic Medical Intl Holding Ltd is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Aesthetic Medical Intl Holding Ltd’s stock price was USD 1.22. Aesthetic Medical Intl Holding Ltd’s stock price has changed by -14.08% over the past week, -7.58% over the past month and -64.64% over the last year.

No recent analyst target price found for Aesthetic Medical Intl Holding Ltd
No recent average analyst rating found for Aesthetic Medical Intl Holding Ltd

About Aesthetic Medical Intl Holding Ltd (AIH:NSD)

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and ene ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-11-29 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

+1.84 (+2.19%)

USD7.66B 27.42 16.51
OPCH Option Care Health Inc

+0.41 (+1.43%)

USD5.25B 28.84 20.02
LHCG LHC Group

-2.80 (-1.67%)

USD5.22B 82.09 31.53
ENSG The Ensign Group Inc

+0.52 (+0.56%)

USD5.14B 24.72 18.40
SGRY Surgery Partners Inc

+0.35 (+1.32%)

USD3.09B 63.00 12.34
AMED Amedisys Inc

-1.80 (-2.00%)

USD2.96B 24.67 13.56
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
LFST Lifestance Health Group Inc

-0.11 (-2.32%)

USD1.92B N/A -9.55
ADUS Addus HomeCare Corporation

-1.00 (-0.92%)

USD1.74B 39.63 22.39
AMEH Apollo Medical Holdings Inc

-0.27 (-0.96%)

USD1.34B 20.44 17.26

ETFs Containing AIH

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -64.94% 30% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.94% 30% F 25% F
Trailing 12 Months  
Capital Gain -52.34% 44% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -52.34% 44% F 33% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -23.83% 16% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.83% 16% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 29.69% 72% C- 55% F
Risk Adjusted Return -80.26% 16% F 9% F
Market Capitalization 0.04B 24% F 20% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.68 89% B+ 75% C
Price/Book Ratio 2.48 62% D- 34% F
Price / Cash Flow Ratio 0.82 52% F 39% F
EV/EBITDA -0.53 59% F 55% F
Management Effectiveness  
Return on Equity -492.08% 4% F 4% F
Return on Invested Capital -87.86% 7% F 15% F
Return on Assets -16.61% 31% F 30% F
Debt to Equity Ratio -73.83% 100% A+ 92% A-
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 7.41 36% F 17% F
Short Percent 8.81% 35% F 18% F
Beta -0.35 96% A 97% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector